STOCK TITAN

Antibe Therapeut Stock Price, News & Analysis

ATBPF OTC

Company Description

Antibe Therapeut (OTC: ATBPF) is a publicly traded medicinal and botanical manufacturing company in the Manufacturing sector.

ATBPF stock has declined 48.6% over the past year.

This page provides a comprehensive overview of ATBPF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
0.00%
0.00
Last updated:
-48.57%
Performance 1 year

Antibe Therapeut (ATBPF) stock. Over the past 12 months, the stock has lost 48.6%.

Latest News

Antibe Therapeut has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include fda approval, conferences, earnings. View all ATBPF news →

SEC Filings

No SEC filings available for ATBPF.

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

ATBPF Company Profile & Sector Positioning

Antibe Therapeut (ATBPF) operates in the Medicinal and Botanical Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.